Showing results (101-110 of 148) with videos related to
Sort By:
Pageof 15
Pediatrics|April 1, 1993
Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosineK M Butler, D Venzon, N Henry, et al.Cancer Research|November 15, 1991
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyP C Adamson, F M Balis, C A Arndt, et al.Antimicrobial Agents and Chemotherapy|June 1, 1990
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primatesT J Walsh, C Lester-McCully, M G Rinaldi, et al.The New England Journal of Medicine|January 17, 1991
Dideoxyinosine in children with symptomatic human immunodeficiency virus infectionK M Butler, R N Husson, F M Balis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Pharmacokinetics of subcutaneous methotrexateF M Balis, J Mirro, G H Reaman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primatesL Long, S L Berg, S K Roy, et al.The Journal of Pediatrics|May 1, 1989
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infectionF M Balis, P A Pizzo, J Eddy, et al.Pediatrics|February 1, 1994
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infectionR N Husson, B U Mueller, M Farley, et al.Cancer Research|September 15, 1987
Pediatric phase I trial and pharmacokinetic study of trimetrexateF M Balis, R Patel, E Luks, et al.Biochemical Pharmacology|June 28, 1996
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsJ L Grem, P M Politi, S L Berg, et al.Pageof 15